Literature DB >> 6178296

Cimetidine and procainamide secretion by proximal tubules in vitro.

T D McKinney, K V Speeg.   

Abstract

Previous studies have shown that organic bases, including some drugs, are secreted by renal proximal tubules. The present studies examined the transport of the organic bases cimetidine and procainamide by rabbit proximal straight tubules perfused in vitro. Both drugs were secreted into the tubule lumen. [3H]cimetidine secretion was reduced by quinidine, procainamide, and N-acetylprocainamide. Previous studies showed that cimetidine secretion was reduced by other organic bases. Hypothermia and ouabain inhibited [3H]procainamide secretion as was shown previously for cimetidine secretion. [3H]procainamide secretion was also reduced by quinidine, cimetidine, procainamide, and N-acetylprocainamide but not by probenecid. High concentrations of cimetidine (10(-3) M) had no effect on the rates of fluid or total CO2 absorption. When analyzed in terms of Michaelis-Menten kinetics, the effect of cimetidine on procainamide secretion and procainamide on cimetidine secretion was consistent with competitive inhibition. The results suggest that both cimetidine and procainamide are secreted into the lumen of proximal straight tubules predominately by an organic base transport mechanism. These studies raise the possibility that some of these drugs might compete for a common secretory mechanism in renal tubules and reduce the elimination of each other.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178296     DOI: 10.1152/ajprenal.1982.242.6.F672

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  Organic and inorganic transporters of the testis: A review.

Authors:  David M Klein; Nathan J Cherrington
Journal:  Spermatogenesis       Date:  2015-01-07

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Renal transport of drugs: an overview of methodology with application to cimetidine.

Authors:  K M Giacomini; P H Hsyu; L G Gisclon
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

5.  Altered flecainide disposition in healthy volunteers taking quinine.

Authors:  A Munafo; G Reymond-Michel; J Biollaz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Renal effects of peptic ulcer therapy.

Authors:  E Burgess; D Muruve
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

7.  Reduction of metformin renal tubular secretion by cimetidine in man.

Authors:  A Somogyi; C Stockley; J Keal; P Rolan; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

8.  Effect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans.

Authors:  R Bendayan; J T Sullivan; C Shaw; R C Frecker; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 9.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

10.  Contraluminal transport of organic cations in the proximal tubule of the rat kidney. II. Specificity: anilines, phenylalkylamines (catecholamines), heterocyclic compounds (pyridines, quinolines, acridines).

Authors:  K J Ullrich; G Rumrich; K Neiteler; G Fritzsch
Journal:  Pflugers Arch       Date:  1992-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.